Healthcare
Cyberdyne Inc.(CYBQF)
Live Price
Offline$1.87
+0.00% today
Window Change
+0.81%
Window
May 29, 2026 โ Jun 18, 2026
- Market Cap
- $38.96B
- Revenue Growth
- -12.3%
- EPS Growth
- +60.9%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars ยท May 29, 2026 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cyberdyne Inc. (CYBQF) is a Healthcare stock with a market cap of $38.96B and listed on OTC. The stock last traded around $1.86 and up 0.8% across the available one-year price window (May 29, 2026 โ Jun 18, 2026). Baseline metrics include revenue growth of -12.3%, EPS growth of +60.9%, a dividend yield of 0.0%. What stands out right now is revenue -12.3%, EPS +60.9%, free cash flow +124.1% with operating margin -15.6% and ROIC -0.5%. Valuation already assumes a fairly strong business story at price/sales 9.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CYBQF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-12.3% vs +7.6% peer median
Operating Margin
Below sector median
-15.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
Q2 2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -12.3% and EPS is at +60.9%, with operating margin around -15.6%.
Benchmark Edge
CYBQF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CYBQF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CYBQF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CYBQF and SPY.
Company Overview
CYBERDYNE Inc.
OTC
Cyberdyne Inc. is a pioneering technology company at the intersection of robotics and medical innovation. Its primary purpose is to develop and implement advanced robotic solutions to augment human capabilities, especially in healthcare settings. The company's flagship product is the Hybrid Assistive Limb (HAL), a wearable exoskeleton designed to support patients experiencing physical disabilities by enhancing mobility and physical strength. Cyberdyne operates extensively within the medical technology industry, providing solutions that facilitate rehabilitation and improve the quality of life for individuals with spinal cord injuries or mobility impairments. Founded in 2004 in Japan, Cyberdyne has made significant contributions to the global medical robotics sector, aiming to revolutionize rehabilitation practices with its cutting-edge technology. By integrating AI and robotics, Cyberdyne plays a crucial role in advancing the limits of human-machine collaboration, setting new standards in therapeutic interventions and assistive devices.
- Leadership
- Dr. Yoshiyuki Sankai
- Employees
- 227
- Street Address
- 2-2-1, Gakuen-Minami
- Mailing
- Tsukuba, 305-0818
- Region
- Tsukuba, Japan
- Last Updated
- May 10, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 9.5
- Price/Book
- 1.5
Growth
- Revenue
- -12.3%
- EPS
- +60.9%
- Free Cash Flow
- +124.1%
Profitability
- Gross Margin
- 58.9%
- Operating Margin
- -15.6%
- Net Margin
- 3.8%
- ROE
- -0.0%
- ROIC
- -0.5%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 1.75
Ownership & Float
- Float
- 100.75M
- Insider Owned
- 23.4%
- Institutional Owned
- 4.7%
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.